Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Prediction Intervals01:03

Prediction Intervals

3.3K
The interval estimate of any variable is known as the prediction interval. It helps decide if a point estimate is dependable.
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y. 
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Exercise Prehabilitation for Older Adults Undergoing CAR-T: Feasibility, Acceptability, and Preliminary Outcomes.

Transplantation and cellular therapy·2026
Same author

Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

Cancer research communications·2026
Same author

Creation of an mHealth Infrastructure to Support the Development and Delivery of mHealth Interventions: Protocol for Demonstration Projects Addressing Smoking Cessation in Cancer Care.

JMIR research protocols·2026
Same author

Pre-clinical efficacy of trastuzumab deruxtecan plus sotorasib in <i>KRAS<sup>G12C</sup></i> -mutant non-small cell lung cancer and exploratory HER2 profiling in human tumors.

Translational lung cancer research·2026
Same author

Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.

Bone marrow transplantation·2026
Same author

Imaging Biomarkers in Radiotherapy.

Cancers·2026

相关实验视频

Updated: Jan 18, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

使用贝叶斯网络来预测接受非小细胞肺癌全身治疗的患者的紧急护理访问.

Brian D Gonzalez1, Xiaoyin Li1, Lisa M Gudenkauf1

  • 1Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL.

JCO clinical cancer informatics
|September 12, 2025
PubMed
概括

整合患者报告结果和可穿戴传感器数据的机器学习模型显著改善了对接受全身治疗的非小细胞肺癌患者紧急护理访问的预测. 这种方法可以提高癌症护理质量和患者的治疗结果.

更多相关视频

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

495
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

910

相关实验视频

Last Updated: Jan 18, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

495
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

910

科学领域:

  • 在瘤学瘤学.
  • 数字健康数字健康
  • 机器学习 机器学习

背景情况:

  • 针对非小细胞肺癌 (NSCLC) 的全身疗法 (ST) 可能导致影响患者结果的毒性.
  • 预测和管理与治疗相关的毒性对于改善患者护理和减少医疗保健利用是至关重要的.

研究的目的:

  • 为了前性地收集患者报告结果 (PRO) 数据,可穿戴传感器数据 (WSD) 和临床数据.
  • 开发一种机器学习 (ML) 算法,用于预测接受ST的NSCLC患者的紧急护理 (UC) 访问.

主要方法:

  • 患有NSCLC的患者在ST期间 (第0-60天) 完成了PROMIS-57并佩戴Fitbit.
  • 从医疗记录中收集了人口统计和临床数据.
  • 开发了可解释贝叶斯网络 (BN) 模型来预测UC访问.

主要成果:

  • 使用人口统计和临床数据的初始BN模型显示UC访问的预测准确度中等 (AUC 0.72-0.81).
  • 整合PRO和WSD显著提高了模型性能 (最终AUC为0.86,P<.001).
  • 该研究包括58名NSCLC患者,平均年龄为69岁.

结论:

  • 多维数据源 (人口统计,临床,PRO,WSD) 改善了医疗保健利用的ML预测模型.
  • 可解释的ML可以预测并潜在地预防治疗毒性和医疗保健利用.
  • 这种方法可以提高患者的治疗结果和癌症护理的质量.